Perspective Therapeutics, Inc. (CATX)
CATX Stock Price Chart
Explore Perspective Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze CATX price movements and trends.
CATX Company Profile
Discover essential business fundamentals and corporate details for Perspective Therapeutics, Inc. (CATX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
10 Nov 2005
Employees
138.00
CEO
Johan M. Spoor
Description
Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is based in Richland, Washington.
CATX Financial Timeline
Browse a chronological timeline of Perspective Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 Nov 2025
EPS estimate is -$0.33, while revenue estimate is $185.35K.
Earnings released on 13 Aug 2025
EPS came in at -$0.30 matching the estimated -$0.30, while revenue for the quarter reached $234.00K , beating expectations by +34.02%.
Earnings released on 12 May 2025
EPS came in at -$0.25 surpassing the estimated -$0.28 by +10.71%, while revenue for the quarter reached $342.00K , beating expectations by +84.01%.
Earnings released on 26 Mar 2025
EPS came in at -$0.25 surpassing the estimated -$0.26 by +3.85%, while revenue for the quarter reached $234.00K , missing expectations by -15.61%.
Earnings released on 12 Nov 2024
EPS came in at -$0.21 matching the estimated -$0.21, while revenue for the quarter reached $369.00K , beating expectations by +26.04%.
Earnings released on 12 Aug 2024
EPS came in at -$0.17 surpassing the estimated -$0.21 by +19.05%, while revenue for the quarter reached $526.00K , beating expectations by +186.68%.
Stock split effective on 17 Jun 2024
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 15 May 2024
EPS came in at -$0.20 surpassing the estimated -$0.30 by +33.33%, while revenue for the quarter reached $325.00K , missing expectations by -11.88%.
Earnings released on 15 Feb 2024
EPS came in at -$0.02 surpassing the estimated -$0.04 by +50.00%, while revenue for the quarter reached $337.00K , missing expectations by -81.28%.
Earnings released on 14 Nov 2023
EPS came in at -$0.40 matching the estimated -$0.40, while revenue for the quarter reached $1.91M , beating expectations by +3.19%.
Earnings released on 11 Aug 2023
EPS came in at -$0.40 falling short of the estimated -$0.30 by -33.33%, while revenue for the quarter reached $1.50M , missing expectations by -42.31%.
Earnings released on 15 May 2023
EPS came in at -$0.01 matching the estimated -$0.01, while revenue for the quarter reached $1.83M , missing expectations by -11.17%.
Earnings released on 16 Feb 2023
EPS came in at -$0.02 falling short of the estimated -$0.01 by -100.00%, while revenue for the quarter reached $1.84M , missing expectations by -37.78%.
Earnings released on 14 Nov 2022
EPS came in at -$0.03 falling short of the estimated -$0.01 by -200.00%, while revenue for the quarter reached $1.72M , missing expectations by -30.92%.
Earnings released on 28 Sept 2022
EPS came in at -$0.01 matching the estimated -$0.01, while revenue for the quarter reached $2.51M , missing expectations by -11.92%.
Earnings released on 10 May 2022
EPS came in at -$0.01 falling short of the estimated -$0.01 by -33.33%, while revenue for the quarter reached $2.91M , meeting expectations.
Earnings released on 8 Feb 2022
EPS came in at -$0.01 falling short of the estimated -$0.01 by -33.33%, while revenue for the quarter reached $2.82M , missing expectations by -4.54%.
Earnings released on 10 Nov 2021
EPS came in at -$0.02 falling short of the estimated -$0.01 by -100.00%, while revenue for the quarter reached $2.56M , missing expectations by -9.09%.
Earnings released on 21 Sept 2021
EPS came in at -$0.01 matching the estimated -$0.01, while revenue for the quarter reached $2.71M , beating expectations by +0.37%.
Earnings released on 13 May 2021
EPS came in at -$0.01 matching the estimated -$0.01, while revenue for the quarter reached $2.60M , meeting expectations.
Earnings released on 9 Feb 2021
EPS came in at -$0.01 matching the estimated -$0.01, while revenue for the quarter reached $2.36M , meeting expectations.
Earnings released on 10 Nov 2020
EPS came in at -$0.01 matching the estimated -$0.01, while revenue for the quarter reached $2.38M , meeting expectations.
CATX Stock Performance
Access detailed CATX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.